Back to search

Article

Lysergic acid diethylamide reverses aging- and neurodegeneration-associated brain transcriptional programs

2026-05-29

Abstract excerpt

<h4>Summary</h4> Psychedelic compounds such as lysergic acid diethylamide (LSD) are increasingly studied for their neuroplastic effects and potential relevance to brain aging and neurodegeneration. However, the molecular mechanisms linking psychedelic-induced plasticity to age-associated cognitive decline remain unclear. Brain aging and dementia are characterized by coordinated transcriptional programs that under...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1947bbbb-9ff8-5f81-b272-55b552ea2145
DOI
10.64898/2026.05.26.727809
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lysergic acid diethylamide reverses aging- and neurodegeneration-associated brain transcriptional programsDOI 10.64898/2026.05.26.727809
Drug repurposing for Alzheimer’s disease based on transcriptional profiling of human iPSC-derived cortical neuronsSemantic proximity
Drug prediction for reversing AD/PD transcriptional profiles using an aging of systems-centric approachSemantic proximity
LSD induces increased signalling entropy in rats’ prefrontal cortexSemantic proximity
Genome-wide reversal of glial and neurovascular cell transcriptomic aging signatures by GLP-1R agonismSemantic proximity
Diazoxide/dibenozylmethane treatment mitigates spatial memory deficits and pathology and upregulates protective genes in an Alzheimer’s transgenic rat modelSemantic proximity
Terazosin drives sex-dependent adrenergic–bioenergetic reprogramming to restore network function in Alzheimer’s diseaseSemantic proximity
Cross-species mapping of psychedelic gene expression reveals links to the 5HT2A receptor, cortical layers, and human accelerated regionsSemantic proximity
Age and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzoleSemantic proximity
Lysergic acid diethylamide pretreatment prolongs brain-stimulation induced neural activity changesSemantic proximity
Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSDSemantic proximity
Cranial Manipulation Affects Cholinergic Pathway Gene Expression in an Animal Model of Age-related Cognitive DeclineSemantic proximity
Cranial Manipulation Modulates Cholinergic Pathway Gene Expression in an Animal Model of Age-related Cognitive DeclineSemantic proximity
Select a neighboring publication to make it the new centre.